BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mourey F, Decherf A, Jeanne JF, Clément-Ziza M, Grisoni ML, Machuron F, Legrain-Raspaud S, Bourreille A, Desreumaux P. Saccharomyces cerevisiae I-3856 in irritable bowel syndrome with predominant constipation. World J Gastroenterol 2022; 28(22): 2509-2522 [PMID: 35979259 DOI: 10.3748/wjg.v28.i22.2509]
URL: https://www.wjgnet.com/1007-9327/full/v28/i22/2509.htm
Number Citing Articles
1
Nathalie Ballet, Sarah Renaud, Hugo Roume, Fanny George, Pascal Vandekerckove, Mickaël Boyer, Mickaël Durand-Dubief. Saccharomyces cerevisiae: Multifaceted Applications in One Health and the Achievement of Sustainable Development GoalsEncyclopedia 2023; 3(2): 602 doi: 10.3390/encyclopedia3020043
2
Chunchen Liu, Ning Ma, Yue Feng, Min Zhou, Huahui Li, Xiujun Zhang, Xi Ma. From probiotics to postbiotics: Concepts and applicationsAnimal Research and One Health 2023; 1(1): 92 doi: 10.1002/aro2.7
3
Maria Napolitano, Ernesto Fasulo, Federica Ungaro, Luca Massimino, Emanuele Sinagra, Silvio Danese, Francesco Vito Mandarino. Gut Dysbiosis in Irritable Bowel Syndrome: A Narrative Review on Correlation with Disease Subtypes and Novel Therapeutic ImplicationsMicroorganisms 2023; 11(10): 2369 doi: 10.3390/microorganisms11102369
4
Michael Camilleri, Saam Dilmaghani. Update on treatment of abdominal pain in irritable bowel syndrome: A narrative reviewPharmacology & Therapeutics 2023; 245: 108400 doi: 10.1016/j.pharmthera.2023.108400
5
Georgios Konstantis, Stylianos Efstathiou, Chryssa Pourzitaki, Elisavet Kitsikidou, Georgios Germanidis, Michail Chourdakis. Efficacy and safety of probiotics in the treatment of irritable bowel syndrome: A systematic review and meta-analysis of randomised clinical trials using ROME IV criteriaClinical Nutrition 2023; 42(5): 800 doi: 10.1016/j.clnu.2023.03.019
6
Peiwei Xie, Mei Luo, Xuehong Deng, Jiahui Fan, Lishou Xiong. Outcome-Specific Efficacy of Different Probiotic Strains and Mixtures in Irritable Bowel Syndrome: A Systematic Review and Network Meta-AnalysisNutrients 2023; 15(17): 3856 doi: 10.3390/nu15173856
7
Wen Xue Zhang, Lu Bo Shi, Min Si Zhou, Jing Wu, Hai Yun Shi. Efficacy of probiotics, prebiotics and synbiotics in irritable bowel syndrome: a systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials Journal of Medical Microbiology 2023; 72(9) doi: 10.1099/jmm.0.001758
8
Yufei Wang, Zhaoxia Liu, Tingtao Chen. Vaginal microbiota: Potential targets for vulvovaginal candidiasis infectionHeliyon 2024; 10(5): e27239 doi: 10.1016/j.heliyon.2024.e27239
9
Min Chen, Lu Yuan, Chao-Rong Xie, Xiao-Ying Wang, Si-Jia Feng, Xin-Yu Xiao, Hui Zheng. Probiotics for the management of irritable bowel syndrome: a systematic review and three-level meta-analysisInternational Journal of Surgery 2023; 109(11): 3631 doi: 10.1097/JS9.0000000000000658
10
Caroline Valibouze, Silvia Speca, Caroline Dubuquoy, Florian Mourey, Lena M'Ba, Lucil Schneider, Marie Titecat, Benoît Foligné, Michaël Genin, Christel Neut, Philippe Zerbib, Pierre Desreumaux. <i>Saccharomyces cerevisiae</i> prevents postoperative recurrence of Crohn's disease modeled by ileocecal resection in HLA-B27 transgenic ratsWorld Journal of Gastroenterology 2023; 29(5): 851-866 doi: 10.3748/wjg.v29.i5.851
11
Ruwen Yang, Jiawei Jiang, Jun Ouyang, Yuanpei Zhao, Biao Xi. Efficacy and safety of probiotics in irritable bowel syndrome: A systematic review and meta-analysisClinical Nutrition ESPEN 2024; 60: 362 doi: 10.1016/j.clnesp.2024.02.025